New Study Finally Knocks Down One of the Biggest Medical
New Study Finally Knocks Down One of the Biggest Medical Marijuana Myths
Matt Connolly's avatar image By Matt Connolly 20 hours ago
The debate over marijuana is raging — except among the patients who use it.
A new study from the Public Health Institute found that 92% of Californians who use medical marijuana say it helps them deal with their ailments. That runs counter to claims of legalization opponents, such as former New York Mayor Michael Bloomberg who called it "one of the great hoaxes of all time."
Legalization isn't without its policy snags: The Colorado Supreme Court is weighing if an employee can be fired for using medical marijuana despite its legal status.
But whether the drug is effective for patients seems to be a closed case, and this study knocks down a myth believed by many opposed to legalization: that legalization of medical marijuana leads to widespread pot use.
"Our study contradicts commonly held beliefs that medical marijuana is being overused by healthy individuals," the authors wrote, noting that patients suffer from a variety of conditions, including arthritis, migraines and cancer. "[The] results lend support to the idea that medical marijuana is used equally by many groups of people and is not exclusively used by any one specific group."
According to the study, about 5% of California adults are medical marijuana users. While white adults and adults ages 18 to 24 were the most common users, every age and racial group had at least a 2% usage rate. Support for medical pot's positive effects cuts across demographic lines.
Chronic pain was the most common condition reported among users, at about 31%. Arthritis and cancer were next at 11%, with migraines following at 8%.
It's not just patients who support the drug. A survey published in the New England Journal of Medicine last year found that 76% of doctors approve of medical marijuana. The study sampled doctors from around the world.
A Pew Research Center poll from earlier this year revealed that three-quarters of respondents think marijuana will eventually be legal nationwide. 23 states currently allow it for medicinal use, while two states — Colorado and Washington — have legalized recreational use. Both numbers could go up depending on the outcome of numerous November ballot initiatives in states including Alaska, Florida and Oregon.
For now, the question of whether medical marijuana works has been answered by those who know best — patients themselves.
h/t Washington Post
#INCC
Tersis Technologies, Inc. (TERS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...
Continue Reading
Jewelry in a safe is dead capital until somebody lends against it. That plain fact sits behind Luxury Asset Capital's latest move: the launch of Palm Beach Loan Company, a South Florida brand aimed at wealthy owners of watches, diamonds, art, handbags, gold, collectibles, and other high-value possessions. The company is not asking clients to sell the stuff they spent...
Continue Reading
A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...
Continue Reading
A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...
Continue Reading
Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...
Continue Reading
Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...
Continue Reading
Cross-border payouts have always had an ugly little problem: money can move digitally in theory, then sit around waiting for banks to wake up in practice. Triple-A’s new collaboration with Visa Direct aims straight at that nuisance in Asia-Pacific, allowing eligible clients to use stablecoins to prefund cross-border payouts while the recipient still gets local currency....
Continue Reading
Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...
Continue Reading
A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...
Continue Reading
Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...
Continue Reading
Top 5 Most Recently Viewed Articles
ParagonX Holdings Shareholder Update ParagonX Holdings, Inc. (OTC:CAVR) recently shared insightful information regarding its transformation and strategic direction. The company is under the management of Caprino Management, LLC, which is actively assessing acquisition opportunities to bolster its growth. Divestitures and Debt Restructuring A significant step taken by...
Continue Reading
Applaud Triumphs with Prestigious AI Award Applaud, a leading innovator in HR technology, has achieved significant recognition in the tech industry. The company’s generative-AI HR platform was awarded the flagship AI Award at a major international event. Applaud was selected among several finalists, showcasing its commitment to providing measurable value to employees...
Continue Reading
Empowering Stories: A Mother's Journey to a New Start Anita's story is one of resilience. Faced with overwhelming challenges in her early life, she fought tirelessly to change her circumstances. Growing up without a family, she was married at a tender age to an older man, and for years, she juggled the responsibilities of motherhood while tending to her husband’s...
Continue Reading
First Capital REIT Announces Distribution for October 2025 First Capital REIT announces its cash distribution for October 2025, setting a notable precedent for its unitholders. The company has declared a distribution of $0.074167 per REIT unit, which translates to an annualized payout of $0.89 per unit. The payment is scheduled for November 17, 2025, to unitholders...
Continue Reading
Stock Market Dynamics: Sidus Space and Others The U.S. stock market is seeing some fluctuations as futures showed little movement earlier today. Among these movements, Nasdaq 100 futures gently slipped by about 0.01%. In the midst of this, shares of Sidus Space, Inc. (NASDAQ: SIDU) are particularly noteworthy. Sidus Space's Price Adjustment Sidus Space recently made...
Continue Reading